Philips’ HealthSuite will track Ypsomed’s connected self-medication devices

 

Philips’ HealthSuite platform will soon connect with Ypsomed’s self-medication devices.

Philips and Ypsomed said today that they will jointly develop a solution for Ypsomed’s new self-medication adherence monitoring services based on Philips’ HealthSuite digital platform.

The combination of Ypsomed’s connected devices and Philips’ (NYSE:PHG) cloud-based digital platform will allow Ypsomed’s pharmaceutical customers to deliver value-added services aimed at improving patient outcomes, the companies said in a joint statement. They intend to sign the definitive agreements in the fourth quarter of 2018.

Get the full story on our sister site, Drug Delivery Business.

The post Philips’ HealthSuite will track Ypsomed’s connected self-medication devices appeared first on MassDevice.

from MassDevice https://ift.tt/2BYyHRd